Advertisement

Journal of Mathematical Biology

, Volume 78, Issue 1–2, pp 497–526 | Cite as

Bone metastasis treatment modeling via optimal control

  • Ariel Camacho
  • Silvia JerezEmail author
Article
  • 183 Downloads

Abstract

Metastatic disease is a lethal stage of cancer progression. It is characterized by the spread of aberrant cells from a primary tumor to distant tissues like the bone. Several treatments are used to deal with bone metastases formation, but they are palliative since the disease is considered incurable. Computational and mathematical models are used to understand the underlying mechanisms of how bone metastasis evolves. In this way, new therapies aiming to reduce or eliminate the metastatic burden in the bone tissue may be proposed. We present an optimal control approach to analyze some common treatments for bone metastasis. In particular, we focus on denosumab treatment, an anti-resorptive therapy, and radiotherapy treatment which has a cell killing action. We base our work in a variant of an existing model introduced by Komarova. The new model incorporates a logistic equation in order to describe the bone metastasis evolution. We provide proofs of existence and uniqueness of solutions to the corresponding optimal control problems for each treatment. Moreover, we present some numerical simulations to analyze the effectiveness of both treatments when different interactions between cancer and bone cells occur. A discussion of the obtained results is provided.

Keywords

Bone metastasis Mathematical modeling Radiotherapy Denosumab Optimal control 

Mathematics Subject Classification

37N25 34H05 92C30 

Notes

Acknowledgements

The authors are grateful to the anonymous reviewers, whose careful observations and helpful suggestions improved considerably the quality of this work. Moreover, AC thanks CONACyT for the Graduate Fellowship Grant 412803. Finally, this work was partially supported by Mexico CONACyT Project CB2016-286437.

References

  1. Araujo A, Cook LM, Lynch CC, Basanta D (2014) An integrated computational model of the bone microenvironment in bone-metastatic prostate cancer. Cancer Res 74(9):2391–2401CrossRefGoogle Scholar
  2. Ayati BP, Edwards CM, Webb GF, Wikswo JP (2010) A mathematical model of bone remodeling dynamics for normal bone cell populations and myeloma bone disease. Biol Direct 5(1):28CrossRefGoogle Scholar
  3. Barker HE, Paget JT, Khan AA, Harrington KJ (2015) The tumour microenvironment after radiotherapy: mechanisms of resistance and recurrence. Nat Rev Cancer 15(7):409CrossRefGoogle Scholar
  4. Bara O, Djouadi SM, Day JD, Lenhart S (2017) Immune therapeutic strategies using optimal controls with L1- and L2- type objectives. Math Biosci 290:1339–1351CrossRefzbMATHGoogle Scholar
  5. Brenner DJ (2008) The linear-quadratic model is an appropriate methodology for determining isoeffective doses at large doses per fraction. Semin Radiat Oncol 8(4):234–239CrossRefGoogle Scholar
  6. Chow E, van der Linden YM, Roos D, Hartsell WF, Hoskin P, Wu JSY, Wong RKS (2016) Single versus multiple fractions of repeat radiation for painful bone metastases: a randomised, controlled, non-inferiority trial. Lancet Oncol 15(2):164–171CrossRefGoogle Scholar
  7. Coelho RM, Lemos JM, Alho I, Valério D, Ferreira AR, Costa L, Vinga S (2016) Dynamic modeling of bone metastasis, microenvironment and therapy. J Theor Biol 391:1–12CrossRefzbMATHGoogle Scholar
  8. De Pillis LG, Radunskaya A (2003) The dynamics of an optimally controlled tumor model: a case study. Math Comput Model 37(11):1221–1244CrossRefzbMATHGoogle Scholar
  9. Dingli D, Chalub FACC, Santos FC, Van Segbroeck S, Pacheco JM (2009) Cancer phenotype as the outcome of an evolutionary game between normal and malignant cells. Br J Cancer 101(7):1130–1136CrossRefGoogle Scholar
  10. Farhat A, Jiang D, Cui D, Keller ET, Jackson TL (2017) An integrative model of prostate cancer interaction with the bone microenvironment. Math Biosci 294:1–14MathSciNetCrossRefzbMATHGoogle Scholar
  11. Fister KR, Lenhart S, McNally JS (1998) Optimizing chemotherapy in an HIV model. Electron J Differ Equ 32:1–12MathSciNetzbMATHGoogle Scholar
  12. Fleming WH, Rishel RW (1975) Deterministic and stochastic optimal control. Springer, New YorkCrossRefzbMATHGoogle Scholar
  13. Florencio-Silva R, Rodrigues G, Sasso-Cerri E, Simoes MJ, Cerri PS (2015) Biology of bone tissue: structure, function, and factors that influence bone cells. Biomed Res Int 2015:421746CrossRefGoogle Scholar
  14. Ganesh V, Chan S, Raman S, Chow R, Hoskin P, Lam H, Chow E (2017) A review of patterns of practice and clinical guidelines in the palliative radiation treatment of uncomplicated bone metastases. Radiother Oncol 124(1):38–44CrossRefGoogle Scholar
  15. Garzón-Alvaradob DA (2012) A mathematical model for describing the metastasis of cancer in bone tissue. Comput Methods Biomech Biomed Eng 15(4):333–346CrossRefGoogle Scholar
  16. Graham JM, Ayati BP, Ramakrishnan PS, Martin JA (2012) Towards a new spatial representation of bone remodeling. Math Biosci Eng 9(2):281–295MathSciNetCrossRefzbMATHGoogle Scholar
  17. Jerez S, Chen B (2015) Stability analysis of a Komarova type model for the interactions of osteoblast and osteoclast cells during bone remodeling. Math Biosci 264:29–37MathSciNetCrossRefzbMATHGoogle Scholar
  18. Jerez S, Camacho A (2018) Bone metastasis modeling based on the interactions between the BMU and tumor cells. J Comput App Math 330:866–876MathSciNetCrossRefzbMATHGoogle Scholar
  19. Jerez S, Díaz-Infante S, Chen B (2018) Fluctuating periodic solutions and moment boundedness of a stochastic model for the bone remodeling process. Math Biosci 299:153–164MathSciNetCrossRefzbMATHGoogle Scholar
  20. Juárez P, Fournier PG, Mohammad KS, McKenna RC, Davis HW, Peng XH, Guise TA (2017) Halofuginone inhibits TGF-\(\beta \)/BMP signaling and in combination with zoledronic acid enhances inhibition of breast cancer bone metastasis. Oncotarget 8(49):86447CrossRefGoogle Scholar
  21. Komarova SV, Smith RJ, Dixon SJ, Sims SM, Wahl LM (2003) Mathematical model predicts a critical role for osteoclast autocrine regulation in the control of bone remodeling. Bone 33(2):206–215CrossRefGoogle Scholar
  22. Kwakwa KA, Vanderburgh JP, Guelcher SA, Sterling JA (2017) Engineering 3D models of tumors and bone to understand tumor-induced bone disease and improve treatments. Curr Osteoporos Rep 15(4):247–254CrossRefGoogle Scholar
  23. Lemaire V, Tobin FL, Greller LD, Cho CR, Suva LR (2004) Modeling the interactions between osteoblast and osteoclast activities in bone remodeling. J Theor Biol 229(3):293–309MathSciNetCrossRefGoogle Scholar
  24. Lemos JM, Caiado DV, Coelho R, Vinga S (2016) Optimal and receding horizon control of tumor growth in myeloma bone disease. Biomed Signal Process 24:128–134CrossRefGoogle Scholar
  25. Lenhart S, Workman JT (2007) Optimal control applied to biological models. Chapman & Hall/CRC, Boca RatonzbMATHGoogle Scholar
  26. Lipton A, Fizazi K, Stopeck AT, Henry DH, Smith MR (2016) Effect of denosumab versus zoledronic acid in preventing skeletal-related events in patients with bone metastases by baseline characteristics. Eur J Cancer 53:75–83CrossRefGoogle Scholar
  27. Lukes DL (1982) Differential equations: classical to controlled. Academic Press, New YorkzbMATHGoogle Scholar
  28. Lutz S, Balboni T, Jones J, Lo S, Petit J, Rich SE, Wong R, Hahn C (2017) Palliative radiation therapy for bone metastases: update of an ASTRO evidence-based guideline. Pract Radiat Oncol 7(1):4–12CrossRefGoogle Scholar
  29. Massagué J, Obenauf AC (2016) Metastatic colonization by circulating tumour cells. Nature 529(7586):298–306CrossRefGoogle Scholar
  30. McAsey M, Mou L, Han W (2012) Convergence of the forward-backward sweep method in optimal control. Comput Optim Appl 53(1):207–226MathSciNetCrossRefzbMATHGoogle Scholar
  31. Mundy GR (2002) Metastasis to bone: causes, consequences and therapeutic opportunities. Nat Rev Cancer 2(8):584–593CrossRefGoogle Scholar
  32. Oest ME, Franken V, Kuchera T, Strauss J, Damron TA (2015) Longterm loss of osteoclasts and unopposed cortical mineral apposition following limited field irradiation. J Orthop Res 33(3):334–342CrossRefGoogle Scholar
  33. Ottewell PD (2016) The role of osteoblasts in bone metastasis. J Bone Oncol 5(3):124–127CrossRefGoogle Scholar
  34. Paget S (1889) The distribution of secondary growths in cancer of the breast. Lancet 133(3421):571–573CrossRefGoogle Scholar
  35. Penninger CL, Patel NM, Niebur GL, Tovar A, Renauda JE (2008) A fully anisotropic hierarchical hybrid cellular automaton algorithm to simulate bone remodeling. Mech Res Commun 35(1–2):32–42CrossRefzbMATHGoogle Scholar
  36. Pivonka P, Zimak J, Smith DW, Gardiner BS, Dunstan CR, Sims NA, Martin TJ, Mundy GR (2008) Model structure and control of bone remodeling: a theoretical study. Bone 43(2):249–263CrossRefGoogle Scholar
  37. Pontryagin LS, Boltyanskiï VG, Gamkrelidze RV, Mischenko EF (1962) The mathematical theory of optimal processes. Wiley, New YorkGoogle Scholar
  38. Ross DS, Mehta K, Cabal A (2017) Mathematical model of bone remodeling captures the antiresorptive and anabolic actions of various therapies. Bull Math Biol 79(1):117–142MathSciNetCrossRefzbMATHGoogle Scholar
  39. Ryser MD, Qu Y, Komarova SV (2012) Osteoprotegerin in bone metastases: mathematical solution to the puzzle. PLoS Comput Biol 8(10):e1002703MathSciNetCrossRefGoogle Scholar
  40. Savageau MA (1988) Introduction to S-systems and the underlying power-law formalism. Math Comput Model 11:546–551MathSciNetCrossRefGoogle Scholar
  41. Stephenson B, Lanzas C, Lenhart S, Day J (2017) Optimal control of vaccination rate in an epidemiological model of Clostridium difficile transmission. J Math Biol 75(6–7):1693–1713MathSciNetCrossRefzbMATHGoogle Scholar
  42. Swan GW (1990) Role of optimal control theory in cancer chemotherapy. Math Biosci 101(2):237–284CrossRefzbMATHGoogle Scholar
  43. Theriault RL, Theriault RL (2012) Biology of bone metastases. Cancer Control 19(2):92–101CrossRefzbMATHGoogle Scholar
  44. Tovar A (2004) Bone remodeling as a hybrid cellular automaton optimization process. Ph.D dissertation, University of Notre Dame, IndianaGoogle Scholar
  45. Vakaet LAM-L, Boterberg T (2004) Pain control by ionizing radiation of bone metastasis. Int J Dev Biol 48(5–6):599–606CrossRefGoogle Scholar
  46. Van Scoy GK, George EL, Asantewaa FO, Kerns L, Saunders MM, Prieto-Langarica A (2017) A cellular automata model of bone formation. Math Biosci 286:58–64MathSciNetCrossRefzbMATHGoogle Scholar
  47. Wang Y, Pivonka P, Buenzli PR, Smith DW, Dunstan CR (2011) Computational modeling of interactions between multiple myeloma and the bone microenvironment. PLoS One 6(11):e27494CrossRefGoogle Scholar
  48. Warman P, Kaznatcheev A, Araujo A, Lynch C, Basanta D (2018) Fractionated follow-up chemotherapy delays the onset of resistance in bone metastatic prostate cancer. Games 9(2):19MathSciNetCrossRefzbMATHGoogle Scholar
  49. Zhang J, Qiu X, Xi K, Hu W, Pei H, Nie J, Zhou G (2018) Therapeutic ionizing radiation induced bone loss: a review of in vivo and in vitro findings. Connect Tissue Res 29:1–14Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.CIMATGuanajuatoMexico

Personalised recommendations